According to Abiomed's latest financial reports the company's current revenue (TTM) is $1.07 B. In 2021 the company made a revenue of $1.00 B an increase over the years 2020 revenue that were of $0.81 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $1.07 B | 7.07% |
2021 | $1.00 B | 23.4% |
2020 | $0.81 B | -3.37% |
2019 | $0.84 B | 14.19% |
2018 | $0.73 B | 35.44% |
2017 | $0.54 B | 31.22% |
2016 | $0.41 B | 36.76% |
2015 | $0.30 B | 42.2% |
2014 | $0.21 B | 20.52% |
2013 | $0.17 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $14.24 B | 1,225.77% | ๐บ๐ธ USA |
Teleflex TFX | $2.97 B | 176.93% | ๐บ๐ธ USA |
AtriCure ATRC | $0.39 B | -62.83% | ๐บ๐ธ USA |